ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to ...

A study, published in Cancer Cell, shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United ...

The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox ...

ITM, a pioneer in radiopharmaceuticals, said it will submit its first drug for approval after reporting the therapy halted ...

The US Food and Drug Administration (FDA) has approved BeiGene’s Tevimbra (tislelizumab-jsgr) along with platinum-containing ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Perakslis is a medical and privacy researcher and has served in the FDA. Stebbins is a health and ... Companies want to see products approved faster for financial reasons, and patients want ...

BUENOS AIRES (Reuters) - The Argentine government has authorized the export of live cattle for slaughter, reversing a prohibition that had been in place for over five decades, after the country's ...

Tata Sons is its top shareholder, with a 92.8% stake as of March 2024. The company separately also approved a 15.04 billion rupees ($173 million) rights issue on Tuesday.

Tata Capital on February 25 said that it has approved plans for an initial public offering which would comprise a combination of fresh issue of 23 crore equity shares and an offer-for sale by ...

President Trump holds a 52 percent approval rating in after his first month back in the Oval Office, polling shows. A Harvard CAPS/Harris survey found that 33 percent strongly approved of the ...

Donald Trump’s approval polling was a bright spot through the first two weeks or so of his second term because the president had really never seen anything like it. Not for himself, that is.